Structural characterization of activation 'intermediate 2' on the pathway to human gastricsin

Nature Structural Biology

Volumn 4, Issue 12, 1997, Pages 1010-1015

  Khan, Amir R ^a   Cherney, Maia M ^a   Tarasova, Nadezhda I ^b   James, Michael N G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; GASTRICSIN;

ARTICLE; CRYSTAL STRUCTURE; ENZYME ACTIVATION; ENZYME SYNTHESIS; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0030811433     PISSN: 10728368     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsb1297-1010     Document Type: Article

References (46)

1. Fusek, M. & Vetvicka, V. Aspartic proteinases: physiology and pathology (CRC Press, New York, New York; 1995).
2. Herriott, R.M. Isolation, crystallization and properties of swine pepsinogen. J. Gen. Physiol. 21, 501-540 (1938).
3. Herriott, R.M. Kinetics of the formation of pepsin from swine pepsinogen and identification of an intermediate compound. J. Gen. Physiol. 22, 65-78 (1939).
4. McPhie, P. A spectrophotometric investigation of the pepsinogen-pepsin conversion. J. Biol. Chem. 247, 4277-4281 (1972).
5. Moore, S.A., Sielecki, A.R., Chernaia, M.M., Tarasova, N.I. & James, M.N.G. Crystal and molecular structures of human progastricsin at 1.62 Å resolution. J. Mol. Biol. 247, 466-485 (1995).
6. James, M.N.G. & Sielecki, A.R. Molecular structure of an aspartic proteinase zymogen, porcine pepsinogen, at 1.8Å resolution. Nature 319, 33-38 (1986).
7. Auer, H.E. & Glick, D.M. Early events of pepsinogen activation. Biochemistry 23, 2735-2739 (1984).
8. Foltmann, B. & Jensen, A.L. Human progastricsin. Analysis of intermediates during activation into gastricsin and determination of the amino acid sequence of the propart. Eur. J. Biochem. 128, 63-70 (1982).
9. Fujinaga, M., Chernaia, M.M., Tarasova, N.I., Mosimann, S.C. & James, M.N.G. Crystal structure of human pepsin and its complex with pepstatin. Protein Sci. 4, 960-972 (1995).
10. Davies, D.R. The structure and function of the aspartic proteinases. Annu. Rev. Biophys. Chem. 19, 189-215 (1990).
11. Schechter, I. & Berger, A. On the size of the active site in proteases. I. Papain Biochem. Biophys. Res. Commun. 27, 157-162 (1967).
12. Yang, J., Teplyakov, A. & Quail, J.W. Crystal structure of the aspartic protease from Rhizomucor miehei at 2.15 Å resolution. J. Mol. Biol. 268, 449-459 (1997).
13. Cutfield, S.M. et al. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. Structure 3, 1261-1267 (1995).
14. Glick, D.M., Shalitin, Y. & Hitt, C.R. Studies on the irreversible step of pepsinogen activation. Biochemistry 28, 2626-2630 (1989).
15. Foltmann, B., Harlow, K., Houen, G., Nielsen, P.K. & Sangild, P. Comparative investigations on pig gastric proteinases and their zymogens, in Aspartic Proteinases: Structure, Function, Biology and Biomedical Implications (ed. Takahashi, K.) 41-51 (Plenum Press, New York; 1995).
16. Nielsen, S. & Foltmann, B. Activation of porcine pepsinogen A: the stability of two non-covalent intermediates at pH 8.5, Eur. J. Biochem, 217, 137-142 (1993).
17. Richardson, J.S. & Richardson, D.C Amino acid preferences for specific locations at the ends of α-helices. Science 240, 1648-1652 (1988).
18. Harper, E.T. & Rose, G.D. Helix stop signals in proteins and peptides: the capping box. Biochemistry 32, 7605-7609 (1993).
19. Dykes, C.W. & Kay, J. Conversion of pepsinogen into pepsin is not a one-step process. Biochem. J. 153, 141-144 (1976).
20. Glick, D.M., Shalitin, Y. & Hilt, CR. Studies on the irreversible step of pepsinogen activation, Biochemistry 28, 2626-2630 (1989).
21. Kageyama, T. et al. Differences of activation processes and structure of activation peptides in human pepsinogens A and progastricsin. J. Biochem. 105, 15-22 (1989)
22. Marciniszyn, Jr., J., Huang, J.S., Hartsuck, J.A. & Tang, J. Mechanism of intramolecular activation of pepsinogen. J. Biol. Chem. 251, 7095-7102 (1976).
23. Athauda, S.B.P., Tanji, M., Kageyama, T. & Takahashi, K. A comparative study on the N-terminal amino acid sequences and some other properties of six isozymic forms of human pepsinogens and pepsins. J. Biochem. 106, 920-927 (1989).
24. Rudenko, G., Booten, E., d'Azzo, A. & Hol, W.G.J. Three-dimensional structure of the 'human protective protein': structure of the precursor form suggests a complex activation mechanism. Structure 15, 1249-1259 (1995).
25. Coulombe, R. et al. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J. 15, 5492-5503 (1996).
26. Cygler, M. et al. Structure of rat procathepsin B. Model for inhibition of cysteine protease activity by the proregion. Structure 4, 405-416 (1996).
27. Turk, D., Podobnik, M., Kuhelj, R., Dolnar, M. & Turk, V. Crystal structures of procathepsin B at 3.2 and 3.3 Å resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide. FEBS Lett 384, 211-214 (1996).
28. Bonten, E.J, et al. Lysosomal protective protein/cathepsin A. Role of the "linker" domain in catalytic activation. J. Biol. Chem. 270, 26441-26445 (1995).
29. Sorenson, S.O., Van den Hazel, H.B., Kielland-Brandt, M.C & Winther, J.R, pH-dependent processing of yeast carboxypeptidase Y by proteinase A in vivo and in vitro. Eur. J. Biochem. 220, 19-27 (1994).
30. Otwinowski, Z. in Data Collection and Processing (eds Sawyer, L., Isaacs, N. & Bailey, S.) 556-562 (SERC Daresbury Laboratory, Warrington, UK; 1993).
31. Navaza, J. AMoRe: an automated package for molecular replacement. Acta Crystallogr. A50, 157-163 (1994).
32. Pannu, N.S. & Read, R.J. Improved structure refinement through maximum likelihood. Acta Crystallogr. A52, 659-668 (1996).
33. Brunger, A.T. XPLOR: a system for X-ray crystallography and NMR (Yale University Press, New Haven, Connecticut; 1993).
34. CCP4, in The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D50, 760-763 (1994).
35. Jones, T.A. & Kjeldgaard, M. O the Manual, Version 5.11 (Uppsala, Sweden; 1995).
36. Esnouf, R.M. An extensively modified version of MolScript that includes greatly enhanced colouring capabilities. J. Mol. Graphics 15, 133-138 (1997).
37. Merritt, E,A. & Murphy, M.E.P, Raster3D version 2.0: a program for photorealistic molecular graphics. Acta Crystallogr. D50, 869-873 (1994).
38. Hayano, T., Sogawa, K., Ichihara, Y., Fuji-Kuriyama, Y. & Takahashi, K. Primary structure of human pepsinogen C gene. J. Biol. Chem. 263, 1382-1385 (1988).
39. Taggart, R.T. et al. Human pepsinogen C (progastricsin). Isolation of cDNA clones, localization to chromosome 6, and sequence homology with pepsinogen A. J. Biol. Chem. 264, 375-379 (1989).
40. Kageyama, T. & Takahashi, K. The complete amino acid sequence of monkey progastricsin. J. Biol. Chem. 261, 4406-4419 (1986).
41. Ichihara, Y., Sogawa, K., Morohashi, K., Fuji-Kuriyama, Y. & Takahashi, K. Nucleotide sequence of a nearly full-length cDNA coding for pepsinogen of rat gastric mucosa. Eur. J. Biochem. 161, 7-12 (1986).
42. Kageyama, T. et al. Gastric procathepsin E and progastricsin from guinea pig. J. Biol. Chem. 267, 16450-16459 (1992).
43. Sogawa, K., Fuji-Kuriyama, Y., Mizukami, Y., Ichihara, Y. & Takahashi, K. Primary structure of human pepsinogen gene. J. Biol. Chem. 258, 5306-5311 (1983).
44. Kageyama, T & Takahashi, K. The complete amino acid sequence of monkey pepsinogen A. J. Biol. Chem. 261, 4395-4405 (1986).
45. Baudys, M. & Kostka, V. Covalent structure of chicken pepsinogen, fur. J. Bioch. 136, 89-99 (1983).
46. Tsukagoshi, N. et al. Nucleotide sequence and expression in Esherichia coli of cDNA of swine pepsinogen: involvement of the amino-terminal portion of the activation peptide segment in restoration of the functional protein. Gene 65: 285-292 (1988).